US Broker Ratings

MBX Biosciences, Inc. (MBX) Investor Outlook: Exploring 206.68% Potential Upside in Biotech Innovation

In the dynamic world of biotechnology, MBX Biosciences, Inc. (MBX) stands out as a promising player with a focus on precision peptide therapies aimed at treating complex endocrine and metabolic..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 44% Upside Potential in the Biotech Space

Niagen Bioscience, Inc. (NAGE) is a rising star in the biotechnology sector, carving a niche for itself in the healthcare industry with a focus on developing products that promote healthy..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating a Healthcare Device Firm with a Unique Market Position

For investors eyeing the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents an intriguing proposition. Headquartered in Santa Clara, California, this company operates within the medical devices industry, catering to..

Personalis, Inc. (PSNL): Analyst Ratings Signal Strong Buy with 8% Upside Potential

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Fremont, California, Personalis is carving out a niche with its..

AbCellera Biologics Inc. (ABCL): Investor Outlook with a 116% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of antibody-based medicines. Headquartered in Vancouver, Canada, the company is..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 90% Potential Upside in the Medical Devices Sector

In the ever-evolving world of medical devices, Standard BioTools Inc. (NASDAQ: LAB) stands out with its intriguing potential for investors. With a market cap of $451.55 million, this healthcare company..

Abivax SA (ABVX) Investor Outlook: Analyzing the 254% Potential Upside

For investors with an appetite for growth in the biotechnology sector, Abivax SA (ABVX) presents a compelling opportunity. With its focus on harnessing the body’s regulatory mechanisms to treat chronic..

Celcuity Inc. (CELC) Investor Outlook: Exploring a Potential 108.83% Upside in Biotechnology

As an emerging leader in the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) is capturing investor attention with its innovative approach to cancer treatment. The company, headquartered in Minneapolis, Minnesota, is..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating the Healthcare Information Landscape

Definitive Healthcare Corp. (NASDAQ: DH) operates within the dynamic healthcare sector, specifically in the health information services industry. Standing at a market capitalization of $431.51 million, this Framingham, Massachusetts-based company..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech with 69.66% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the biotech sector, attracting investor interest with an impressive potential upside of 69.66%. This clinical-stage biopharmaceutical company is actively engaged in developing..

Kura Oncology, Inc. (KURA) Investor Outlook: Exploring a Potential 289.81% Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is capturing investor attention with its innovative approach to cancer treatment and a striking potential upside..

STAAR Surgical Company (STAA) Stock Analysis: Evaluating the 10.60% Potential Upside Amidst Market Challenges

STAAR Surgical Company (NASDAQ: STAA), an innovator in the healthcare sector, particularly in medical instruments and supplies, is attracting attention with its advanced implantable lens technology. Based in Lake Forest,..

Mind Medicine (MindMed) Inc. (MNMD) Investor Outlook: Potential Upside of 175.90% Amid Strong Buy Ratings

Mind Medicine (MindMed) Inc. (MNMD), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising pipeline and impressive potential upside. Based in New York,..

CorMedix Inc. (CRMD) Stock Analysis: Biotech’s Hidden Gem with 71.64% Potential Upside

Investors with an eye on the healthcare sector have likely come across CorMedix Inc. (NASDAQ: CRMD), a promising player in the biotechnology industry. With a market cap of $823.93 million,..

Investor Outlook: Surmodics, Inc. (SRDX) Faces Challenges Amidst Healthcare Device Innovation

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, stands at a pivotal moment as it navigates a challenging market environment. With a market..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: 152% Upside Potential Sparks Investor Interest

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising name in the biotechnology sector, has been capturing investor attention with its ambitious pipeline of treatments targeting severe autoimmune and inflammatory diseases. Founded..

Sage Therapeutics, Inc. (SAGE) Stock Report: Navigating the Biotech Waves Amidst a 78% Revenue Growth

Sage Therapeutics, Inc. (NASDAQ: SAGE), a beacon in the biotechnology sector, is captivating investor attention with its impressive 78% revenue growth. Headquartered in Cambridge, Massachusetts, Sage Therapeutics focuses on pioneering..

ATAI Life Sciences N.V. (ATAI): Investor Outlook on a Biotech with 222% Upside Potential

ATAI Life Sciences N.V. (NASDAQ: ATAI), a player in the burgeoning field of mental health pharmaceuticals, is capturing investor attention with its impressive potential upside. Currently trading at $2.79, ATAI..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 38.20% Potential Upside in Healthcare

Fortrea Holdings Inc. (FTRE), a prominent player in the biotechnology sector, has caught the attention of investors with a compelling 38.20% potential upside. As a contract research organization, Fortrea specializes..

Cross Country Healthcare, Inc. (CCRN) Investor Outlook: Is a 44% Upside Within Reach?

Investors eyeing Cross Country Healthcare, Inc. (CCRN) will find themselves at a crossroads, evaluating the potential for a significant upside against the backdrop of current market dynamics. As a key..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds